Novo Nordisk A/S announced a share repurchase program initiated on May 6, 2024, to buy back B shares for up to DKK 2.2 billion until August 5, 2024, part of a larger DKK 20 billion program starting February 6, 2024. As of June 14, 2024, they have repurchased 9,703,295 B shares at an average price of DKK 868.99 per share, totaling approximately DKK 8.4 billion.